Lotte Steuten, Ph.D., M.Sc.

Lotte Steuten Ph.D., M.Sc.
faculty member

Lotte Steuten, Ph.D., M.Sc.

Associate Faculty Member
Hutchinson Institute for Cancer Outcomes Research (HICOR), Fred Hutch

Fax: 206.667.5977
Mailstop: M3-B232

Dr. Lotte Steuten strives to accelerate patient access to high-value health care innovations. She has deep expertise in health economics and evidence development that she applies to identifying and articulating the clinical, humanistic and economic value of medical technologies and precision medicine, particularly regarding cancer. As a faculty member of the Hutchison Institute for Cancer Outcomes Research, she conducts comparative-effectiveness research to determine which health care interventions work best for which cancer patients. Dr. Steuten has led health-economic groups in the U.S., U.K. and the Netherlands and serves as an adviser to research organizations, policy boards and health care organizations worldwide. Her research skills include decision-analytic modeling to assess the value of health care technology at each stage of technology development.

Other Appointments & Affiliations

Adjunct Associate Professor
University of Washington School of Pharmacy


B.S., Health Sciences, Maastricht University, Maastricht, NL, 1997-2000

M.Sc, Health Science Research, Maastricht University, Maastricht, NL 2000-2001

PhD, cum laude Health Economic Evaluation; Faculty of Health Sciences, Maastricht University, Maastricht, NL 2001-2006

Research Interests

Dr. Steuten’s research interests include developing and applying health economic and decision-analytic research methods to accelerate patient access to high value new screening, diagnostic and treatment options against cancer. Her research expertise is in the fields of health economics and health services research. She specializes in developing and applying quantitative (Bayesian) methods for estimating and comparing the expected health and economic benefits of new approaches and interventions in cancer prevention and treatment, and prioritizing data collection to efficiently build the evidence for such promising new interventions.

Current Projects

A Sero-Epidemiologic Survey and Cost-Effectiveness Study of Screening for HIV, HBV and HCV among Newly Diagnosed Cancer Patients

Clinical and Economic Value of Next Generation Sequencing-Based Diagnostic Testing in Cancer Care

BMT CTN 1101 Ancillary Cost-Effectiveness Analysis

Cost Effectiveness Analysis of Stem Cell Transplant in Older MDS Patients

Statistical Methods for Evaluating Markers for Treatment Selection

The Comparative Clinical Effectiveness and Value of Emicizumab for Treatment of Hemophilia A

Statistical Methods for Genetic Epidemiologic Studies

Economic Burden of Pancreatic Ductal Adenocarcinoma

Comprehensive Colorectal Cancer Risk Prediction To Inform Personalized Screening

EDRN: Data Management and Coordinating Center

Find A Clinical Trial

Dr. Steuten in the News

Fred Hutch at ASCO

Hutch News - June 05, 2018

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210